{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:58Z","timestamp":1777865278218,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Spanish National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PIE-RD-COVID-19 Ref"],"award-info":[{"award-number":["PIE-RD-COVID-19 Ref"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["202020E079"],"award-info":[{"award-number":["202020E079"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118475","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:22:52Z","timestamp":1765930972000},"page":"118475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery and SAR studies of antiviral 4-aminopiperidine derivatives active against SARS-CoV-2"],"prefix":"10.1016","volume":"304","author":[{"given":"Sergio","family":"Algar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hristo","family":"Anatoliev-Dimitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessy","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Trifero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urtzi","family":"Garaigorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Gastaminza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-1932","authenticated-orcid":false,"given":"Christophe","family":"Dardonville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118475_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/mco2.26","article-title":"Coronavirus in human diseases: mechanisms and advances in clinical treatment","volume":"1","author":"Lin","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2025.118475_bib2","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-385885-6.00009-2","article-title":"Chapter 4 - coronavirus pathogenesis","author":"Weiss","year":"2011"},{"key":"10.1016\/j.ejmech.2025.118475_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118475_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/d41573-022-00074-6","article-title":"Pan-coronavirus vaccine pipeline takes form","volume":"21","author":"Dolgin","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118475_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2025.118475_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118475_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118475_bib8","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41422-021-00570-1","article-title":"Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2","volume":"31","author":"Xie","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118475_bib9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118475_bib10","series-title":"WHO Updates its Guidance on Treatments for Covid-19","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118475_bib11","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s12325-025-03218-3","article-title":"Therapeutic approaches for COVID-19: a review of antiviral treatments, immunotherapies, and emerging interventions","volume":"42","author":"Alves","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejmech.2025.118475_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/v17081064","article-title":"SARS-CoV-2 infection and antiviral strategies: advances and limitations","volume":"17","author":"Soares","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.118475_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118475_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12985-023-02210-z","article-title":"What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms","volume":"20","author":"Aboul-Fotouh","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.ejmech.2025.118475_bib15","article-title":"Repurposing existing drugs for the treatment ofCOVID-19\/SARS-CoV-2: a review of pharmacological effects and mechanism of action","volume":"10","author":"Liang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.118475_bib16","doi-asserted-by":"crossref","first-page":"36858","DOI":"10.1021\/acsomega.4c05357","article-title":"Repurposed drugs during the outbreak of pandemic COVID-19: a mini-review on their molecular structures and hit-and-trial results","volume":"9","author":"Devi","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118475_bib17","series-title":"III Jornadas Cient\u00edficas PTI+ Salud Global","article-title":"CSIC chemical library (QCSIC): a new challenge after the COVID-19 outbreak","author":"Izquierdo Garc\u00eda","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118475_bib18","series-title":"II Jornadas Cient\u00edficas PTI+ Salud Global","article-title":"CSIC chemical library (Quimioteca CSIC)","author":"Ruiz","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118475_bib19","unstructured":"https:\/\/quimioteca.csic.es."},{"key":"10.1016\/j.ejmech.2025.118475_bib20","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1021\/acs.jmedchem.3c00576","article-title":"C-2 thiophenyl tryptophan trimers inhibit cellular entry of SARS-CoV-2 through interaction with the viral spike (S) protein","volume":"66","author":"Gargantilla","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118475_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00249-008-0338-4","article-title":"Quantitative modeling of selective lysosomal targeting for drug design","volume":"37","author":"Trapp","year":"2008","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.ejmech.2025.118475_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.abi4708","article-title":"Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2","author":"Tummino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118475_bib23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.1840080514","article-title":"Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease","volume":"8","author":"Guigui","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.118475_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118475_bib25","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/cmi.12340","article-title":"Lipid interactions during virus entry and infection","volume":"16","author":"Mazzon","year":"2014","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118475_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574508","article-title":"Targeting lipid rafts\u2014A potential therapy for COVID-19","volume":"11","author":"Sviridov","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118475_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.micinf.2006.10.015","article-title":"Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle","volume":"9","author":"Li","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ejmech.2025.118475_bib28","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.csbj.2021.04.001","article-title":"Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification","volume":"19","author":"Li","year":"2021","journal-title":"Comput. Struct. Biotech. J."},{"key":"10.1016\/j.ejmech.2025.118475_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28658","article-title":"Viruses and phospholipids: friends and foes during infection","volume":"95","author":"Rattay","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejmech.2025.118475_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/hsz-2019-0270","article-title":"Emerging mechanisms of drug-induced phospholipidosis","volume":"401","author":"Breiden","year":"2020","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118475_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1100028","article-title":"Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific","volume":"13","author":"Diesendorf","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118475_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007280","article-title":"Phospholipid synthesis fueled by lipid droplets drives the structural development of poliovirus replication organelles","volume":"14","author":"Viktorova","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.118475_bib33","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.3390\/molecules26237208","article-title":"Synthesis, biological evaluation, and structure\u2013activity relationships of 4-Aminopiperidines as novel antifungal agents targeting ergosterol biosynthesis","volume":"26","author":"Krau\u00df","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118475_bib34","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118475_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00249-005-0012-z","article-title":"Probing the interaction between vesicular stomatitis virus and phosphatidylserine","volume":"35","author":"Carneiro","year":"2006","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.ejmech.2025.118475_bib36","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1074\/jbc.M708955200","article-title":"Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein","volume":"283","author":"Sun","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118475_bib37","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.118475_bib38","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1128\/AAC.02619-14","article-title":"Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine","volume":"58","author":"Mingorance","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118475_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1073\/pnas.0912966107","article-title":"Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection","volume":"107","author":"Gastaminza","year":"2010","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118475_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/acsinfecdis.0c00491","article-title":"Targeting polyamines inhibits coronavirus infection by reducing cellular attachment and entry","volume":"7","author":"Firpo","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118475_bib41","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/ph14101048","article-title":"SARS-CoV-2 fears green: the chlorophyll catabolite pheophorbide A is a potent antiviral","volume":"14","author":"Jimenez-Aleman","year":"2021","journal-title":"Pharmaceuticals"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:09:14Z","timestamp":1777529354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"alternative-id":["S0223523425012401"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118475","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and SAR studies of antiviral 4-aminopiperidine derivatives active against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118475"}}